Quanterix Corporation $QTRX Stock Position Decreased by Valmark Advisers Inc.

Valmark Advisers Inc. lowered its holdings in Quanterix Corporation (NASDAQ:QTRX) by 57.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 105,382 shares of the company’s stock after selling 139,472 shares during the period. Valmark Advisers Inc. owned approximately 0.21% of Quanterix worth $701,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of QTRX. Invenomic Capital Management LP purchased a new stake in shares of Quanterix in the first quarter valued at $5,872,000. Trium Capital LLP purchased a new stake in shares of Quanterix in the first quarter valued at $3,642,000. Nuveen LLC purchased a new stake in shares of Quanterix in the first quarter valued at $2,704,000. Topline Capital Management LLC purchased a new stake in shares of Quanterix in the first quarter valued at $2,513,000. Finally, Easterly Investment Partners LLC lifted its holdings in shares of Quanterix by 38.8% in the first quarter. Easterly Investment Partners LLC now owns 1,325,620 shares of the company’s stock valued at $8,630,000 after purchasing an additional 370,625 shares in the last quarter. Hedge funds and other institutional investors own 86.48% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on QTRX. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quanterix in a report on Wednesday. Canaccord Genuity Group reiterated a “hold” rating and set a $5.00 price objective (down from $12.00) on shares of Quanterix in a report on Monday, August 11th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $11.75.

Quanterix Price Performance

NASDAQ QTRX opened at $5.99 on Friday. Quanterix Corporation has a fifty-two week low of $4.05 and a fifty-two week high of $15.67. The stock’s 50-day moving average is $5.08 and its two-hundred day moving average is $5.51. The firm has a market cap of $278.33 million, a P/E ratio of -3.29 and a beta of 1.07.

Quanterix (NASDAQ:QTRX) last posted its earnings results on Thursday, August 7th. The company reported ($0.47) earnings per share for the quarter, missing the consensus estimate of ($0.41) by ($0.06). Quanterix had a negative net margin of 56.04% and a negative return on equity of 18.41%. The company had revenue of $24.48 million for the quarter, compared to the consensus estimate of $29.73 million. Quanterix has set its FY 2025 guidance at EPS. On average, equities analysts expect that Quanterix Corporation will post -0.98 EPS for the current year.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.